We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Global Partnership Provides Treatment Planning Support for Modulated Arc Radiotherapy

By MedImaging International staff writers
Posted on 22 Sep 2014
Print article
Varian Medical Systems (Palo Alto, CA, USA) Eclipse treatment planning software can now be used to plan modulated arc radiotherapy (mARC) treatments at sites using Siemens Healthcare (Erlangen, Germany) medical linear accelerators.

Varian Medical Systems and Siemens Healthcare presented their range of solutions that integrate Siemens’ diagnostic imaging technologies with Varian’s therapeutic systems for treating cancer with image-guided radiotherapy, radiosurgery, proton therapy, and brachytherapy at the 55th annual meeting of the American Society for Radiation Oncology (ASTRO), held in San Francisco (CA, USA), in September 2014.

As part of their global strategic partnership, the two companies presented new capabilities within Varian’s Eclipse treatment planning software that can now enable delivery of mARC treatments using Siemens existing medical linear accelerators. mARC radiotherapy is Siemens’ approach to volumetric-modulated arc therapy (VMAT), a highly efficient way to deliver a precisely-sculpted dose to a targeted tumor.

“Over the years of our partnership, Varian and Siemens have worked to create seamless connectivity between our two companies’ solutions,” said Kolleen Kennedy, president of Varian’s oncology systems business. “This development marks an important new milestone in our mutual cooperation, and demonstrates our commitment to the community of Siemens technology users.”

The two companies, in previous years of the partnership, focused on creating Varian Exchange, an interface that makes it possible to use Varian’s ARIA oncology information system in treatment centers using Siemens linear accelerators. This interface has now been successfully deployed in 11 treatment centers in the United States and worldwide, and is slated to be installed in 16 more. Kiel University Hospital (Germany) was the first site in the world to use this interface to connect the ARIA system from Varian to Siemens Artiste accelerators.

“Prior to our having this connectivity, Digital Imaging and Communications in Medicine [DICOM)]-based export of information between systems was slow and there were clinical restrictions that resulted,” said chief medical physicist Dr. Frank-André Siebert, PhD. “The whole patient workflow was hard to follow and every minor change needed a completely new treatment plan, which was very time-consuming.”

Dr. Siebert noted that the workflow is much more streamlined with Eclipse and ARIA fully connected to the treatment machines. “It’s much easier and faster to work with just one software system rather than two,” he said. “Two systems need more care than one and are more expensive to service.”

Related Links:

Varian Medical Systems
Siemens Healthcare


Portable Color Doppler Ultrasound Scanner
DCU10
Digital Radiographic System
OMNERA 300M
Wall Fixtures
MRI SERIES
New
Biopsy Software
Affirm® Contrast

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more